Five Prime Therapeutics Inc (FPRX) Cotización

While its pulled back as expected from its PR post peak price, the last 3 days show it trying to hold the $17.3 level which is right where the Moving Average timeline I use is at.

BUT, the momentum indicators I use have turned negative so expecting it to breakdown some more from here.

Still looking to see if the GAP theory will apply here, ie, will the GAP that took place on the day of the PR be 'filled'?

disclaimer: own PUTs on it, ie, placed a bet to challenge myself whether or not what I think will happen, happens.. IF it breaks down below $17.20??

and last I checked, around 90,000 shares traded up till around 2 PM implying that whoever is holding shares, has either decided to 'sit tight' with them and at the same time, not too many interested in accumulating at the moment. Perfect setup for a decision to develop of, can it hold or does it drop... before the next PR takes place..

Any troops on guard
This baby tanked big after I got in Monday

had a few more minutes to look into this one.. Just got into their clinical trials, 3 in 'progress', with the most advanced one being the PH 2... But just caught that this PH 2 is not scheduled to complete till the time period of 2022-2024.. then a PH 3 has to be run??

This one isn't worth a $5 spot let alone $20... wow, wonder who in the heck is buying shares at this price level, this far in advance...

disclaimer: what am I missing?? But do own some PUTS due to the perceived overvaluation..

correct me if I am wrong, but they say they have 35 Million shares outstanding, just indicated they are going to sell ATM 5 Million more..

And today, 22 Million shares traded...

yesterday it was 75 Million...

In many circles, that is one heck of a lot of 'turnover' going on..

interesting..

wonder how many now own positions with a cost basis above $20/sh??

disclaimer: Day 2 post PH 2 data release..

* * $FPRX Video Chart 11-12-2020 * *

Link to Video - click here to watch the technical chart video

Yaa that will be broken soon imo??

24.00 was. Brick wall

Nope someone dont want it go above that imo

help me understand this one here:

-this was just a phase 2 trial. Results appear good enough to get a PH 3 designed and run (at least 2 years to complete??)

-they just announced a 5 Million share at the market share sale. This far out, and with no earnings, no need to talk about the dilutive effect on 35 Mil shares outstanding, for I expect there will be more secondaries in the future..

-they just lost 74 cents/sh in the last quarter IF I read their earnings release correctly..

To me, this looks like a classic Wall Street pump and dump set up... designed to help the company raise money on relatively weak news with respect to future earnings/revenues cause its only a PH 2..

So what am I missing?? That justifies folks paying up to $24-26/sh for something not worth $5 for at least another full year??

disclaimer: said it yesterday that I bought Dec $5 Puts with the share price at $19.60... (was up 60%+ at the close last night on them, laughing this morn when I saw it opening up as it did, wondering what in the hell are folks doing as I explained to my son how MOMENTUM and NOISE can make people do foolish things)

Blue skies it is!!

If it breaks 24 then i thinks its blue sky imo??

Up 17.6% early hours

Keep finely tuned

* * $FPRX Video Chart 11-11-2020 * *

Link to Video - click here to watch the technical chart video

Yup seems like offering is coming imo?? Already a bagholder here lol

added FPRX to short list

I'm watching, leary of the offerings that seem to follow these so I'd be in and out.....roulette

So how low will this go today?

Profitable trading so far.....

Morning...
another board alerted me to the 'news' of yesterday on this one. But this is only a PH 2, and while I have never shorted a stock, IF this thing jumps this morn in the premarket, I will be looking to buy PUTS on it.. (but the current option range isn't conducive to a good PUT trade unless they add some strike prices.. damn...)

and those with gains, as this was only a PH 2, you may seriously want to consider locking those gains in. Cause unless they can get fast tracked off this Ph 2 to approval, the share price is NOT likely to hold...

not with at least a 2 year PH 3 to run..

looking at a chart this morn in the pre market, up at $21 at the moment, but on very light volume... not a good time or price to be buying at. Mercy, seen this horror show too many times before..

disclaimer: just heard about this one this morn, a few minutes ago, enough time to read thru yesterdays news, see that its a PH 2 and having been around bio developments for around 20 years, will be looking to PUT this one. But added it to my 'watch list', going to investigate it closer, watch its PH3 development... see what its future holds.. Good luck.

Opens 30’s

$102 a share, your right

GOOD CALL. FPRX IS NOW 300% UP

$10 2morrow

Biotechnology Value Fund just keeps adding so taken a starter position.
Mark Lampert seeks positions with heavy derisking and downside cushion, provided via past data sets.

https://whalewisdom.com/filer/bvf-inc-il#tabholdings_tab_link

has earned a spot on tonights trade ideas: msmoneymoves.com/2019/12/02/trade-ideas-for-aug-21/

[msmoneymoves.com/2019/12/02/trade-ideas-for-aug-21/]

* * $FPRX Video Chart 10-09-2019 * *

Link to Video - click here to watch the technical chart video

11:11 on Ash Wednesday go tribe!

Two Biotech Companies Rated Strong Buys for the New Year - article discusses FPRX

http://marketexclusive.com/two-biotech-companies-rated-strong-buys-for-the-new-year/1219/

$FPRX recent news/filings

bullish 40.38

## source: finance.yahoo.com

Tue, 15 Dec 2015 17:58:34 GMT ~ Five Prime Therapeutics, Inc. Earnings Analysis: Q3, 2015 By the Numbers


read full: http://www.capitalcube.com/blog/index.php/five-prime-therapeutics-inc-earnings-analysis-q3-2015-by-the-numbers/
*********************************************************

Tue, 08 Dec 2015 18:17:14 GMT ~ FIVE PRIME THERAPEUTICS INC Financials


read full: http://finance.yahoo.com/q/is?s=fprx
*********************************************************

Thu, 03 Dec 2015 21:30:38 GMT ~ FIVE PRIME THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers


read full: http://biz.yahoo.com/e/151203/fprx8-k.html
*********************************************************

Thu, 03 Dec 2015 21:16:11 GMT ~ Five Prime Therapeutics Appoints Drug Development Leaders to Board of Directors

[at noodls] - December 1, 2015 SOUTH SAN FRANCISCO, Calif., Dec. 1, 2015 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) (Five Prime), a clinical-stage biotechnology company focused on discovering and ...

read full: http://www.noodls.com/view/C96DBB6578034A6B7034E5123F1AABDDB0A63266
*********************************************************

Thu, 03 Dec 2015 21:05:00 GMT ~ Five Prime Therapeutics Appoints Drug Development Leaders to Board of Directors

[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif. -- Five Prime Therapeutics, Inc. , a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, ...

read full: http://finance.yahoo.com/news/five-prime-therapeutics-appoints-drug-210500872.html
*********************************************************

$FPRX charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$FPRX company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/FPRX/company-info
Ticker: $FPRX
OTC Market Place: Not Available
CIK code: not found
Company name: Five Prime Therapeutics, Inc.
Incorporated In:

Business Description:

$FPRX share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$FPRX extra dd links

Company name: Five Prime Therapeutics, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=FPRX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=FPRX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=FPRX+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/FPRX/news - http://finance.yahoo.com/q/h?s=FPRX+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/FPRX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/FPRX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=FPRX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/FPRX
DTCC (dtcc.com): http://search2.dtcc.com/?q=Five+Prime+Therapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Five+Prime+Therapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Five+Prime+Therapeutics%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/FPRX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/FPRX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/FPRX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=FPRX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=FPRX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/FPRX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=FPRX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=FPRX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=FPRX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=FPRX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=FPRX+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/FPRX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=FPRX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/FPRX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=FPRX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/FPRX/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/FPRX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/FPRX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/FPRX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=FPRX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=FPRX



$FPRX DD Notes ~ http://www.ddnotesmaker.com/FPRX

But it's not the type of gap that "has to close." Even if it does close, which it may never do, it'll be months from now.

Covered short

Large GAP to close

FPRX is in the Loncar Cancer Immunotherapy Index ETF:

http://www.loncarindex.com/

http://www.fool.com/investing/general/2015/10/16/the-lazy-way-to-invest-in-cancer-immunotherapy.aspx?source=eptadnlnk0000002&utm_source=advfn&utm_medium=cpc&utm_campaign=investorshub

Secondaries coming!

Check insider transactions

Nothing stopping this beast!

Heading to $33.00+ today.

Shorted @ 27.9

Read about the BMY Opdivo AEs here:

http://tinyurl.com/oaqvm2m

Will the FPRX collaboration solve the problems? I do not know.

FPRX 28 gonna be a good one

BMY,FPRX,...Bristol-Myers Squibb expands collaboration with Five Prime Therapeutics in a deal worth up to $1.74B; Five Prime up 62% premarket

Bristol-Myers Squibb (BMY) goes all in with Five Prime Therapeutics (FPRX) in a license and collaboration deal worth up to $1.74B. The partnership will focus on the development of Five Prime's colony stimulating factor 1 receptor (CSF1R) antibody program, including FPA008, in combination with Opdivo (nivolumab) and other therapies.

The new agreement replaces the companies' existing collaboration to evaluate Opdivo with FPA008 in six tumor types.Under the terms of the agreement, Five Prime will receive an upfront payment of $350M, up to $1.05B in development and regulatory milestones for CSF1R oncology indications (including combinations with Opdivo and any other agent), up to $340M in development and regulatory milestones for CSF1R non-oncology indications and double-digit royalties on commercial sales (higher if Five Prime elects to co-promote in the U.S.).

HUGE DEAL WITH BMY!!!!!

$FPRX recent news/filings

bullish

## source: finance.yahoo.com

Thu, 28 May 2015 20:48:14 GMT ~ Five Prime Therapeutics to Present at the Jefferies Healthcare Conference

[at noodls] - SOUTH SAN FRANCISCO, Calif., May 28, 2015 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) (Five Prime), a clinical-stage biotechnology company focused on discovering and developing novel ...

read full: http://www.noodls.com/view/619FF8CC7A5F58C8436BC8B9B7B3A9150666A0A7
*********************************************************

Thu, 28 May 2015 20:05:00 GMT ~ Five Prime Therapeutics to Present at the Jefferies Healthcare Conference

[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif. -- Five Prime Therapeutics, Inc. (Five Prime), a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory ...

read full: http://finance.yahoo.com/news/five-prime-therapeutics-present-jefferies-200500519.html
*********************************************************

Thu, 28 May 2015 13:35:55 GMT ~ BMO Capital: Five Prime Therapeutics Still A Buy, Worth $31/Share Now


read full: http://finance.yahoo.com/news/bmo-capital-five-prime-therapeutics-133555954.html
*********************************************************

Thu, 28 May 2015 12:51:12 GMT ~ Five Prime Therapeutics (FPRX) Jumps: Stock Rises 15.1% - Tale of the Tape


read full: http://finance.yahoo.com/news/five-prime-therapeutics-fprx-jumps-125112334.html
*********************************************************

Tue, 26 May 2015 20:29:08 GMT ~ bluebird bio and Five Prime Therapeutics Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy

[at noodls] - CAMBRIDGE, Mass. and SOUTH SAN FRANCISCO, Calif., May 26, 2015 (GLOBE NEWSWIRE) -- bluebird bio, Inc. (Nasdaq:BLUE) and Five Prime Therapeutics, Inc. (Nasdaq:FPRX) today announced that they have entered ...

read full: http://www.noodls.com/view/82BB7F0D646D0790A5247344045D650DA8A4922C
*********************************************************

$FPRX charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$FPRX company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/FPRX/company-info
Ticker: $FPRX
OTC Market Place: Not Available
CIK code: not found
Company name: Five Prime Therapeutics, Inc.
Incorporated In:

Business Description:

$FPRX share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available

$FPRX extra dd links

Company name: Five Prime Therapeutics, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=FPRX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=FPRX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=FPRX+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/FPRX/news - http://finance.yahoo.com/q/h?s=FPRX+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/FPRX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/FPRX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=FPRX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/FPRX
DTCC (dtcc.com): http://search2.dtcc.com/?q=Five+Prime+Therapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Five+Prime+Therapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Five+Prime+Therapeutics%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/FPRX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/FPRX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/FPRX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=FPRX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=FPRX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/FPRX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=FPRX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=FPRX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=FPRX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=FPRX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=FPRX+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/FPRX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=FPRX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/FPRX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=FPRX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/FPRX/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/FPRX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/FPRX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/FPRX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=FPRX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=FPRX



$FPRX DD Notes ~ http://www.ddnotesmaker.com/FPRX

This is not falling lol you get burned shorty?

$FPRX DD Notes ~ http://www.ddnotesmaker.com/FPRX

bullish
agreement and funding from Bristol-Myers for a promising cancer drug study, so they can be first in the line on any partnerships later

$FPRX recent news/filings

## source: finance.yahoo.com

Fri, 28 Nov 2014 13:34:06 GMT ~ The Zacks Analyst Blog Highlights: BioMarin, Prosensa, Five Prime Therapeutics, AbbVie, Amgen, Biogen and Vertex


read full: http://finance.yahoo.com/news/zacks-analyst-blog-highlights-biomarin-133406574.html
*********************************************************

Wed, 26 Nov 2014 20:30:02 GMT ~ Five Prime Therapeutics Up on Deal with Bristol-Myers


read full: http://finance.yahoo.com/news/five-prime-therapeutics-deal-bristol-203002800.html
*********************************************************

Tue, 25 Nov 2014 21:19:08 GMT ~ Five Prime Therapeutics to Present at The 26th Annual Piper Jaffray Healthcare Conference

[at noodls] - SOUTH SAN FRANCISCO, Calif., Nov. 25, 2014 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX) (Five Prime), a clinical-stage biotechnology company focused on discovering and developing novel ...

read full: http://www.noodls.com/view/EA612BBC663494F7E67976EBAD764F4EC584CA67
*********************************************************

Tue, 25 Nov 2014 21:05:00 GMT ~ Five Prime Therapeutics to Present at The 26th Annual Piper Jaffray Healthcare Conference

[GlobeNewswire] - SOUTH SAN FRANCISCO, Calif. -- Five Prime Therapeutics, Inc. (Five Prime), a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory ...

read full: http://finance.yahoo.com/news/five-prime-therapeutics-present-26th-210500127.html
*********************************************************

Tue, 25 Nov 2014 10:55:11 GMT ~ Five Prime Therapeutics, Inc. (FPRX) in Focus: Stock Soars 31.4%


read full: http://finance.yahoo.com/news/five-prime-therapeutics-inc-fprx-105511043.html
*********************************************************


$FPRX charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com


$FPRX company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/FPRX/company-info
Ticker: $FPRX
OTC Market Place: Not Available
CIK code: not found
Company name: Five Prime Therapeutics, Inc.
Incorporated In:

Business Description:


$FPRX share structure

## source: otcmarkets.com

Market Value: Not Available
Shares Outstanding: Not Available
Float: Not Available
Authorized Shares: Not Available
Par Value: Not Available
$FPRX extra dd links

Company name: Five Prime Therapeutics, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=FPRX+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=FPRX+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=FPRX+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/FPRX/news - http://finance.yahoo.com/q/h?s=FPRX+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/FPRX/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/FPRX/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=FPRX+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/FPRX
DTCC (dtcc.com): http://search2.dtcc.com/?q=Five+Prime+Therapeutics%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Five+Prime+Therapeutics%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Five+Prime+Therapeutics%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/FPRX
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/sec-filings
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/FPRX/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/FPRX/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=FPRX&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=FPRX
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/FPRX/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=FPRX+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=FPRX+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=FPRX
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=FPRX
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=FPRX+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/FPRX/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=FPRX+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/FPRX.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=FPRX
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/FPRX/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/FPRX/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/FPRX
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/FPRX
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/FPRX:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=FPRX
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=FPRX



$FPRX DD Notes ~ http://www.ddnotesmaker.com/FPRX

FPRX Falling like a piano out the window of a five story Manhattan walk-up..

At 10:15AM -4.83% @ 19.70, 111K

Received first downgrade this morning:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108494379

FPRX Closed AH session -.17 tonight on very light volume of 5.8K

I think we'll quickly see a retrace following Monday's momo action- there's nothing to support a 7.7x's book value for a twelve year old company that has only completed a single safety trial of 39 people.

MG

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=108486427

I haven't looked at them closely enough to form a definitive opinion. I realize IPF is not an easy indication so am willing to give them a pass (I believe the J&J collaboration was when I first heard of them). It seems to me they've been touting their library since at least then whether it is just taking time to develop/partner or its not as valuable as it would seem is something I would want to get comfortable with first. Their former CMO went to (and is now out of) Nektar too (I didn't find her especially impressive).

I did find BIND appealing at a low valuation to take a position but the real value may be early stage/with partners we don't know much about.

No specific program, but rather the platform and the low valuation. What about you?

Is there a particular program that you find interesting?

I used to pay more attention to them years ago when I kept better tabs on PAH and IPF programs as I believe they were involved in both through partnerships. I see they still have some IPF interest.